Table 2.
Comparison of demographic and clinical characteristics between confirmed COVID‐19 cases in patients with β‐thalassaemias based on disease outcome.
|
Recovered N = 11 |
Dead N = 4 |
P value | |
|---|---|---|---|
| Age (year), Median (min–max) | 36 (22–66) | 32·5 (30–60) | 0·949 |
| Sex (m) (n, %) | 5 (45·5) | 2(50) | >0·999 |
| Thalassaemia type (TDT) (n, %) | 11 (100) | 1(25) | 0·009 |
| Splenectomy (yes) (n, %) | 9 (81·8) | 3 (75) | >0·999 |
| Haemoglobin (g/l) median (min–max) | 87 (79–97) | 95 (82–99) | 0·226 |
| Serum ferritin (ng/ml) >2000 (n, %) | 3 (27·3) | 0 | >0·999 |
| White blood cell count (per µl), median (min–max) | 12 300 (63–31 900) | 12 000 (3775–34 360) | >0·999 |
| Platelet count (per µl), median (min–max) | 589 500 (840–848 000) | 582 500 (147 000–965 000) | 0·808 |
| Hydroxycarbamide (yes) (n, %) | 1 (9·1) | 2 (50) | 0·154 |
| Heart or liver iron overload (moderate and severe) (n, %) | 4 (36·4) | 1 (25) | >0·999 |
| Comorbidities (n, %) | 8 (72·7) | 4 (100) | 0·516 |
| Major underlying disease* (n, %) | 3 (27·3) | 4 (100) | 0·026 |
*
Heart disease, Diabetes, pulmonary artery hypertension, and hypertension.